historymanagementboard of directors investors

press releasespress coverageelectronic press kit

media

  BOARD OF DIRECTORS

Axel Bolte
Investment Advisor, HBM Partners

Paul Chaney
Independent

Thomas Dyrberg, M.D., Ph.D.
Partner, Novo A/S

Lutz Giebel, Ph.D.
Managing Partner, SV Life Sciences
 
David Schnell, M.D.
Managing Director, Prospect Venture Partners

Dean J. Mitchell
President & Chief Executive Officer

 

   
  © 2012 Lux Biosciences, Inc. All rights reserved. Web Terms Enlarged Text
   
   

 

LUVENIQ™LX214LX212proprietary technologiespipeline

uveitisdry eye syndrome

indicationstechnologies

aboutophthalmicproducts &partnersnews &careerscontact us